Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Methicillin-Resistant Staphylococcus aureus | 2 | 2012 | 67 | 0.720 |
Why?
|
| Staphylococcal Infections | 2 | 2012 | 115 | 0.710 |
Why?
|
| Community-Acquired Infections | 2 | 2012 | 87 | 0.480 |
Why?
|
| Carrier State | 1 | 2012 | 18 | 0.420 |
Why?
|
| Antibodies, Bacterial | 2 | 2012 | 193 | 0.420 |
Why?
|
| Shiga-Toxigenic Escherichia coli | 1 | 2010 | 7 | 0.370 |
Why?
|
| Leukocidins | 1 | 2010 | 8 | 0.360 |
Why?
|
| Exotoxins | 1 | 2010 | 9 | 0.360 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2010 | 5 | 0.360 |
Why?
|
| Bacteriological Techniques | 1 | 2010 | 28 | 0.360 |
Why?
|
| Metapneumovirus | 1 | 2010 | 6 | 0.350 |
Why?
|
| Paramyxoviridae Infections | 1 | 2010 | 7 | 0.350 |
Why?
|
| Bacterial Toxins | 1 | 2010 | 60 | 0.350 |
Why?
|
| Soft Tissue Infections | 1 | 2010 | 45 | 0.340 |
Why?
|
| Escherichia coli Infections | 1 | 2010 | 87 | 0.340 |
Why?
|
| Infant | 5 | 2012 | 1527 | 0.250 |
Why?
|
| Child, Preschool | 5 | 2012 | 1843 | 0.240 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2002 | 7 | 0.210 |
Why?
|
| Tongue Diseases | 1 | 2020 | 4 | 0.180 |
Why?
|
| Conjunctivitis | 1 | 2020 | 5 | 0.180 |
Why?
|
| Adolescent | 5 | 2020 | 5939 | 0.180 |
Why?
|
| Exanthema | 1 | 2020 | 27 | 0.180 |
Why?
|
| Child | 4 | 2012 | 4324 | 0.170 |
Why?
|
| Genes, Bacterial | 2 | 2012 | 117 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2002 | 843 | 0.140 |
Why?
|
| Needlestick Injuries | 1 | 2015 | 19 | 0.130 |
Why?
|
| Accidents, Occupational | 1 | 2015 | 55 | 0.120 |
Why?
|
| Molecular Typing | 1 | 2012 | 8 | 0.100 |
Why?
|
| Burkholderia Infections | 1 | 2012 | 2 | 0.100 |
Why?
|
| Burkholderia cepacia complex | 1 | 2012 | 2 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2012 | 67 | 0.100 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2012 | 43 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2012 | 188 | 0.100 |
Why?
|
| DNA, Bacterial | 1 | 2012 | 260 | 0.090 |
Why?
|
| Shiga Toxin | 1 | 2010 | 4 | 0.090 |
Why?
|
| Male | 5 | 2020 | 27765 | 0.090 |
Why?
|
| Immunoassay | 1 | 2010 | 52 | 0.090 |
Why?
|
| Seroepidemiologic Studies | 1 | 2010 | 48 | 0.090 |
Why?
|
| Culture Media | 1 | 2010 | 77 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 207 | 0.090 |
Why?
|
| Serologic Tests | 1 | 2010 | 34 | 0.090 |
Why?
|
| Boston | 1 | 2010 | 333 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2010 | 238 | 0.080 |
Why?
|
| Respiratory Tract Infections | 1 | 2010 | 80 | 0.080 |
Why?
|
| Immunocompromised Host | 1 | 2010 | 95 | 0.080 |
Why?
|
| Female | 5 | 2012 | 31093 | 0.080 |
Why?
|
| Humans | 8 | 2020 | 59799 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 525 | 0.080 |
Why?
|
| Prevalence | 1 | 2012 | 1288 | 0.080 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 452 | 0.080 |
Why?
|
| Pneumococcal Vaccines | 1 | 2007 | 19 | 0.070 |
Why?
|
| Fimbriae, Bacterial | 1 | 2007 | 19 | 0.070 |
Why?
|
| Indians, North American | 1 | 2007 | 26 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 906 | 0.070 |
Why?
|
| Meningococcal Vaccines | 1 | 2007 | 28 | 0.070 |
Why?
|
| Pneumococcal Infections | 1 | 2007 | 35 | 0.070 |
Why?
|
| Logistic Models | 1 | 2010 | 1252 | 0.070 |
Why?
|
| Streptococcus pneumoniae | 1 | 2007 | 59 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2012 | 2461 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2100 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1460 | 0.060 |
Why?
|
| Prognosis | 1 | 2010 | 1584 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2007 | 397 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2010 | 751 | 0.060 |
Why?
|
| Frameshift Mutation | 1 | 2002 | 28 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 148 | 0.050 |
Why?
|
| Genes | 1 | 2002 | 96 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2002 | 92 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2002 | 114 | 0.050 |
Why?
|
| Pedigree | 1 | 2002 | 191 | 0.050 |
Why?
|
| DNA Mutational Analysis | 1 | 2002 | 196 | 0.050 |
Why?
|
| Point Mutation | 1 | 2002 | 164 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2002 | 120 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2012 | 6041 | 0.050 |
Why?
|
| Tongue | 1 | 2020 | 17 | 0.050 |
Why?
|
| Base Sequence | 1 | 2002 | 1311 | 0.040 |
Why?
|
| RNA | 1 | 2002 | 404 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 1976 | 0.040 |
Why?
|
| DNA | 1 | 2002 | 793 | 0.040 |
Why?
|
| Anesthesia, Local | 1 | 2015 | 19 | 0.030 |
Why?
|
| Mutation | 1 | 2002 | 2461 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 315 | 0.030 |
Why?
|
| Occupational Exposure | 1 | 2015 | 309 | 0.030 |
Why?
|
| Blood Bactericidal Activity | 1 | 2012 | 70 | 0.020 |
Why?
|
| Health Personnel | 1 | 2015 | 343 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2012 | 253 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2012 | 235 | 0.020 |
Why?
|
| Massachusetts | 1 | 2015 | 2111 | 0.020 |
Why?
|
| Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2007 | 5 | 0.020 |
Why?
|
| Serotyping | 1 | 2007 | 50 | 0.020 |
Why?
|
| Nasopharynx | 1 | 2007 | 21 | 0.020 |
Why?
|
| Virulence | 1 | 2007 | 189 | 0.020 |
Why?
|
| Adult | 1 | 2002 | 15879 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2079 | 0.010 |
Why?
|
| Vaccination | 1 | 2007 | 340 | 0.010 |
Why?
|
| Mice | 1 | 2012 | 10303 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2007 | 5204 | 0.010 |
Why?
|
| Animals | 1 | 2012 | 19718 | 0.010 |
Why?
|